Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.
- DOI
- 10.1016/j.mayocp.2023.12.021
- Published
- 2024 Oct
- Container
- Mayo Clinic proceedings
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mayocp.2023.12.021,
title = {Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.},
author = {Talmor-Barkan Y and Yu J and Yacovzada NS and Pravda NS and Ayers C and de Lemos JA and Tang WHW and Hazen SL and Eisen A and Witberg G and Kornowski R and Neeland IJ},
year = {2024},
journal = {Mayo Clinic proceedings},
doi = {10.1016/j.mayocp.2023.12.021},
url = {https://doi.org/10.1016/j.mayocp.2023.12.021}
}RIS
TY - JOUR TI - Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study. AU - Talmor-Barkan Y AU - Yu J AU - Yacovzada NS AU - Pravda NS AU - Ayers C AU - de Lemos JA AU - Tang WHW AU - Hazen SL AU - Eisen A AU - Witberg G AU - Kornowski R AU - Neeland IJ PY - 2024 JO - Mayo Clinic proceedings DO - 10.1016/j.mayocp.2023.12.021 UR - https://doi.org/10.1016/j.mayocp.2023.12.021 ER -
APA
Y, T., J, Y., NS, Y., NS, P., C, A., JA, D. L., WHW, T., SL, H., A, E., G, W., R, K., & IJ, N. (2024). Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.. Mayo Clinic proceedings. https://doi.org/10.1016/j.mayocp.2023.12.021
Source records
- pubmed · retrieved 2026-09-25T12:24:25.338Z
- europe-pmc · retrieved 2026-09-25T12:24:25.347Z